Treatment Registry
TR-0521 ActiveRecorded September 2026Last verified October 2026

Compounded tirzepatide

Sold by PrescribedRX · Injection · device not recorded · every compounded tirzepatide record

The program identifies an injection, but the delivery device has not been established.

Price

TermPer monthCharged today
Three-month tirzepatide plan

Prescription and clinician approval required.

“3 month plan $597 $199/mo”

Per month$199Charged today$597
Price sources
Visit PrescribedRX

We earn nothing from this link. It opens PrescribedRX's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberAsynchronous review
CancellationAutomatically renews every three months. Cancel before the renewal date to avoid the next charge; renewed periods are not refundable. Treatment is fully refunded if a provider finds it inappropriate. The purchase terms permit some pre-consultation refunds but make a prescription final and nonrefundable once issued and transmitted to the pharmacy, even before shipment. Requested prescription changes after transmission may cost up to $150. Certain therapies may retain charges through a minimum commitment. https://prescribedrx.com/purchase-terms/
MembershipNone. “The homepage advertises no membership or cancellation fees; medication and care are included in the plan.”
Consult feeIncluded in program price; itemized amount is not published. Provider review, medication, supplies, portal support and priority shipping are included in the three-month program price.

Recorded from prescribedrx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Vial form confirmed indirectly via the purchase-terms disclaimer 'The medical vials and bottles displayed on the PrescribedRx website are for marketing and illustrative purposes only.' States coverage is only a single-state exclusion note ('Not available in North Carolina'), not a served-list, so states.list is left empty per the brief. Purchase terms disclose a $99 administrative fee may apply on a pre-consultation cancellation, a $150 reprocessing fee for prescription changes, and that 'certain therapies require minimum commitments due to medical protocols' with charges continuing through the commitment period even if shipments are cancelled — genuinely more restrictive than the homepage's blanket 'Transparent, Upfront Pricing... no hidden fees' framing, worth flagging as a contradiction between marketing copy and the actual terms. No sync/async description of the provider visit was found.
  2. 2. October 2026 — The current offer is $597 for a three-month supply ($199 per month equivalent), billed every three months, including care, supplies and shipping. Current pages do not establish the earlier ten-week offer or a separate monthly-plan price. The provider reviews the submitted answers, and clinical refusal receives a full treatment refund. https://prescribedrx.com/plans/tirzepatide/
  3. 3. October 2026 — Actual administration is injection. Pictures are explicitly illustrative and do not confirm a dispensed vial, so the earlier vial classification was too specific. The current product page says the service is not available in every state but does not publish a served-state roster or name its dispensing pharmacy. https://prescribedrx.com/plans/tirzepatide/
  4. 4. October 2026 — Current purchase terms do not repeat the older $99 pre-consultation administrative fee. The current policy separately describes a possible charge of up to $150 for prescription modification or reprocessing after pharmacy transmission. Cancel-anytime language concerns future renewals and does not override the nonrefund or minimum-commitment terms. https://prescribedrx.com/purchase-terms/

2 further notes concern other PrescribedRX programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0521
Medication category
compounded tirzepatide
Readings
2

Related records

Cite this entry

Treatment Registry. (2026). PrescribedRX — compounded tirzepatide (TR-0521). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0521

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.